MYCN and glioblastoma: The latter include decreased global H3K27me38,15,25 and increased MYCN (notably in both our K27M and G34R-mutated cells) that was also observed in studies of pediatric GBM specifically with H3.3G34(R/V) mutation13,26 but had not been previously reported in K27M cells.